FY2025 Earnings Forecast for PAHC Issued By Zacks Research

Phibro Animal Health Co. (NASDAQ:PAHC) – Zacks Research lifted their FY2025 EPS estimates for Phibro Animal Health in a note issued to investors on Wednesday, March 12th. Zacks Research analyst R. Department now anticipates that the company will post earnings per share of $1.91 for the year, up from their prior forecast of $1.87. The consensus estimate for Phibro Animal Health’s current full-year earnings is $1.95 per share.

Several other equities analysts also recently issued reports on the stock. Morgan Stanley boosted their price target on shares of Phibro Animal Health from $20.00 to $25.00 and gave the company an “equal weight” rating in a report on Tuesday, December 17th. Barclays boosted their price target on shares of Phibro Animal Health from $20.00 to $22.00 and gave the stock an “underweight” rating in a research report on Monday, February 10th. Finally, StockNews.com upgraded shares of Phibro Animal Health from a “hold” rating to a “buy” rating in a research report on Saturday. Two equities research analysts have rated the stock with a sell rating, two have assigned a hold rating and one has given a buy rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $21.00.

Phibro Animal Health Stock Down 1.1 %

PAHC stock opened at $21.62 on Monday. The company has a debt-to-equity ratio of 2.99, a current ratio of 3.20 and a quick ratio of 1.37. Phibro Animal Health has a 1-year low of $12.07 and a 1-year high of $26.55. The firm has a fifty day moving average price of $22.62 and a two-hundred day moving average price of $22.59. The firm has a market cap of $875.67 million, a price-to-earnings ratio of 45.04, a PEG ratio of 0.45 and a beta of 0.58.

Phibro Animal Health (NASDAQ:PAHC) last issued its quarterly earnings results on Wednesday, February 5th. The company reported $0.54 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.40 by $0.14. Phibro Animal Health had a net margin of 1.75% and a return on equity of 25.35%.

Hedge Funds Weigh In On Phibro Animal Health

Several hedge funds and other institutional investors have recently added to or reduced their stakes in PAHC. Vanguard Group Inc. grew its stake in shares of Phibro Animal Health by 1.4% in the fourth quarter. Vanguard Group Inc. now owns 1,514,736 shares of the company’s stock worth $31,809,000 after acquiring an additional 20,604 shares during the last quarter. American Century Companies Inc. lifted its position in Phibro Animal Health by 18.0% in the fourth quarter. American Century Companies Inc. now owns 635,599 shares of the company’s stock worth $13,348,000 after purchasing an additional 96,787 shares during the period. Nuveen Asset Management LLC lifted its position in Phibro Animal Health by 21.4% in the fourth quarter. Nuveen Asset Management LLC now owns 588,001 shares of the company’s stock worth $12,348,000 after purchasing an additional 103,618 shares during the period. Renaissance Technologies LLC lifted its position in Phibro Animal Health by 1.9% in the fourth quarter. Renaissance Technologies LLC now owns 557,800 shares of the company’s stock worth $11,714,000 after purchasing an additional 10,600 shares during the period. Finally, Geode Capital Management LLC lifted its position in Phibro Animal Health by 1.7% in the fourth quarter. Geode Capital Management LLC now owns 515,979 shares of the company’s stock worth $10,838,000 after purchasing an additional 8,510 shares during the period. Institutional investors and hedge funds own 99.34% of the company’s stock.

Phibro Animal Health Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, March 26th. Investors of record on Wednesday, March 5th will be paid a $0.12 dividend. The ex-dividend date of this dividend is Wednesday, March 5th. This represents a $0.48 annualized dividend and a dividend yield of 2.22%. Phibro Animal Health’s payout ratio is 100.00%.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.